
 Scientific claim: Increased purity of cytoplasmic membranes isolated from overexpressors is indicated by stronger spots for OmpF in 2D BN-PAGE gels. 
 Participant Dynamics: Beneficiary vs. Authority 
 Contextual Arena: The Didactic Arena (goal: to teach or learn) 
 Interaction Trigger: An External Mandate (a new law, policy, or trend) 
 Dialogue Objective: To Reach a Decision (choose or reject an action) 
```
Dr. White: So, Dr. Blake, let's discuss the new directive from the research board. They've mandated a review of our membrane isolation procedures.

Dr. Blake: Yes, I heard about that. They want us to ensure our methods align with the latest findings. Specifically, the increased purity of cytoplasmic membranes isolated from overexpressors is indicated by stronger spots for OmpF in 2D BN-PAGE gels.

Dr. White: Precisely. The directive aims to improve our data integrity. They believe that better purity leads to more accurate results, which is crucial for our current project.

Dr. Blake: Understood, but implementing these new procedures will require additional resources and time. We need to decide if it's worth the investment.

Dr. White: I agree, but consider this: the stronger spots for OmpF as seen in the gels provide a more reliable measure of purity. It’s a significant step forward in our analytical capabilities.

Dr. Blake: True, but there's also the question of scalability. Our current setup might not support these changes without significant upgrades.

Dr. White: That's a valid point. However, if we adopt these procedures, we could potentially publish findings that are more robust. The board is likely to support us with additional funding if we present a strong case.

Dr. Blake: That’s promising. We should also consider training the team on the new methods. It’s essential to maintain consistency across all experiments.

Dr. White: Absolutely. Let's prepare a proposal outlining the benefits, costs, and training requirements. We can present it to the board as justification for the necessary resources.

Dr. Blake: Agreed. I'll start drafting the proposal. It’s essential we reach a decision soon to align with the directive's timeline.

Dr. White: Perfect. Let’s reconvene after the draft is ready. We need to ensure our approach is both scientifically sound and feasible.

Dr. Blake: I'll have the draft ready by the end of the week. Thank you for the input, Dr. White.

Dr. White: Anytime, Dr. Blake. Let’s move forward with confidence.
```